Long-term follow-up of anxiety and depression in cancer patients
A Single-center, Real-world Prospective Observational Study of the Incidence and Development of Anxiety and Depression in Patients With Malignant Tumors
This study is trying to see how anxiety and depression affect cancer patients over time and how it relates to their treatment and recovery.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 200 (estimated) |
| Sex | All |
| Sponsor | Henan Cancer Hospital Government |
| Locations | 1 site (Zhengzhou, Henan) |
| Trial ID | NCT05596344 on ClinicalTrials.gov |
What this trial studies
This observational study aims to enroll 200 patients with malignant tumors at Henan Cancer Hospital to assess their levels of anxiety and depression over time. It will collect data on patients' basic information, treatment, and prognosis, utilizing the Hospital Anxiety and Depression Scale for evaluation. The study is designed to provide insights into the psychological impact of cancer on patients and how it correlates with their treatment outcomes.
Who should consider this trial
Good fit: Ideal candidates include men and women of all ages with a pathological diagnosis of malignant tumors who have been hospitalized at Henan Cancer Hospital.
Not a fit: Patients without a pathological report of malignancy will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance understanding of the psychological challenges faced by cancer patients, leading to improved mental health support and treatment strategies.
How similar studies have performed: Other studies have shown success in understanding the psychological effects of cancer, indicating that this approach is supported by existing research.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Men and women of all ages are welcome. 2. Pathological diagnosis of malignant tumor in our hospital. 3. Received at least one hospitalization at this hospital. 4. The expected survival time is greater than 1 year. Exclusion Criteria: 1.There was no pathological report of malignancy.
Where this trial is running
Zhengzhou, Henan
- Department of Bone and Soft Tissue ,Henan Cancer Hospital — Zhengzhou, Henan, China (Recruiting)
Study contacts
- Study coordinator: Wang Jiaqiang, Dr
- Email: wjqwtj@126.com
- Phone: 13592413731
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.